Loblaw Companies Ltd (L.TO)
Investor Insights
Aug 3, 2026, 12:00 am This summary was created by AI, based on 13 opinions in the last 12 months.
Loblaw Companies Ltd, the largest food and drug retailer in Canada, has garnered mixed reviews from analysts, with many acknowledging its defensive nature and solid market position. Experts appreciate the growth after the acquisition of Shoppers Drug Mart, contributing to strong profitability and free cash flow. The company faces challenges from growing competition, particularly from Walmart and Costco, but its private label offerings have proven resilient during inflationary periods. While some analysts highlight the current high valuation and express concerns over sustainability, the overall sentiment suggests it remains a core defensive portfolio choice amid economic uncertainty.
Loblaw Companies Ltd (L.TO) Frequently Asked Questions
What is Loblaw Companies Ltd stock symbol?
Loblaw Companies Ltd is a Canadian stock, trading under the symbol L.TO (previously L-T on Stockchase) on the Toronto Stock Exchange (L-CT). It is usually referred to as TSX:L or L.TO
Is Loblaw Companies Ltd a buy or a sell?
In the last year, 12 stock analysts issued a Buy, Sell, or Hold rating on L.TO (previously L-T on Stockchase). 6 analysts recommended to BUY and 4 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Loblaw Companies Ltd.
Is Loblaw Companies Ltd worth watching?
Loblaw Companies Ltd is followed by 322 investors on Stockchase and is a trending stock that is worth watching.
What is Loblaw Companies Ltd stock price?
On 2026-07-31, Loblaw Companies Ltd (L.TO) stock closed at a price of $65.81.